Lewis Lung Carcinoma is a type of cancer that takes its name from the laboratory where it was first discovered. The word "Lewis" is spelled using the phonetic transcription /ˈluːɪs/, with the stress on the first syllable. "Lung" is spelled using the phonetic transcription /lʌŋ/, with the stress on the first syllable. "Carcinoma" is spelled using the phonetic transcription /kɑːsɪˈnoʊmə/, with the stress on the second syllable. Understanding the proper spelling of medical terms is important to ensure accurate communication in healthcare settings.
Lewis lung carcinoma is a type of cancer that originates from the lungs and is classified as a pulmonary carcinoma. It is named after its discoverer, Dr. Dorothy Lewis, who developed and characterized this tumor in mice during her research. This type of lung carcinoma is commonly used as a model for studying lung cancer in experimental settings.
Lewis lung carcinoma is characterized by the uncontrolled growth and division of abnormal cells in the lung tissues. These malignant cells have the capability to invade nearby tissues and spread to distant organs. As a result, it can cause various symptoms, including chronic cough, shortness of breath, chest pain, and unintentional weight loss.
Histologically, Lewis lung carcinoma is known to be an undifferentiated carcinoma, meaning the cells lack specific features and do not resemble normal lung tissues. This tumor is often adenocarcinoma-like or squamous cell-like, which are subtypes of non-small cell lung cancer. However, it is important to note that Lewis lung carcinoma is specific to mice and has not been identified in humans.
Due to its well-characterized features, Lewis lung carcinoma has been extensively studied and used in cancer research. It has served as a valuable model for investigating the biology of lung cancer, testing experimental therapies, and evaluating the efficacy of anticancer drugs.